NewsBenzinga일루미나, 분자 잔류 질환 및 종양 진화에 대한 초민감 연구 지원을 위한 조기 액세스 프로그램 출시 일루미나, 분자 잔류 질환 및 종양 진화에 대한 초민감 연구 지원을 위한 조기 액세스 프로그램 출시 Benzinga 2026.11.09 14:19 (GMT+0) Open on Benzinga Other news Nvidia China Trouble Could Spill Over to These AI Chip Stocks Trump says ex-Nvidia CEO Jensen Huang’s affair with an alleged Chinese spy did not threaten national security Tiger Global Management Takes New Stake In Ferrari N V With 602,700 Shares Citigroup Maintains Neutral on EOG Resources, Raises Price Target to $155 Citigroup Maintains Neutral on Rivian Automotive, Lowers Price Target to $14.5 Trump Backs Jensen Huang’s Return to Nvidia as Sam Altman Says 'Heroes Have Flaws'
Trump says ex-Nvidia CEO Jensen Huang’s affair with an alleged Chinese spy did not threaten national security